New Issue: Stereotaxis raises $60 million in spot follow-on sale of 5 million shares at $12, versus $14 close

By Ronda Fears

Memphis, Jan. 27 - Surgical instrument maker Stereotaxis, Inc. sold 5 million shares in a spot follow-on sale at $12 per share, discounted from Thursday's close of $14, via bookrunner Deutsche Bank Securities Inc.

St. Louis-based Stereotaxis makes advanced cardiology instrument control system for use in a hospital's interventional surgical suite to enhance the treatment of coronary artery disease and arrhythmias.

Issuer:	Stereotaxis, Inc.
Issue:	Follow-on stock offering
Proceeds:	$60 million
Shares:	5 million shares
Price:	$12.00 per share
Bookrunner:	Deutsche Bank Securities Inc.
Co-managers:	A.G. Edwards & Sons, Inc. and HSBC Securities (USA) Inc.
Pricing date:	Jan. 26
Settlement date:	Feb. 1
Stock symbol:	Nasdaq: STXS
Stock price:	$14.00 at close Jan. 26

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.